Analytical & Bioanalytical Services
Contract Research Organization
Regulatory, Tech Transfer & Support Services
Company Overview
About
KCAS Bio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Neurology
Quick Facts
HQ:Australia
Founded:2007
Employees:1,303
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval FTGR74
PMDA · #APR-9VF52J1U · 2018-12-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-9PKA2UYC
Issued: 2020-07-09
Expires: 2025-01-18
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-VPGBUNPQ
Issued: 2020-07-01
Expires: 2025-07-18
Loading CDMO intelligence...
Key facts about KCAS Bio
- KCAS Bio is headquartered in Australia.
- KCAS Bio was founded in 2007.
- KCAS Bio has 1,303 employees.
- KCAS Bio's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like KCAS Bio
Directory pages this company appears in, each with the full list of matching manufacturers.